On July 8, 2026, NewcelX Ltd. announced the appointment of Dr. Camillo Ricordi, a specialist in diabetes cure research, to its Scientific Advisory Board. This appointment is intended to support the company's scientific initiatives. NewcelX Ltd. is a biotechnology company focused on developing treatments for diabetes.
